Reanimation in Tetraplegia



Status:Active, not recruiting
Conditions:Hospital
Therapuetic Areas:Other
Healthy:No
Age Range:21 - 89
Updated:8/31/2018
Start Date:November 2013
End Date:June 2019

Use our guide to learn which trials are right for you!

The purpose of this clinical study is to allow the investigation of the Neural Bridging
System for participants with tetraplegia to assess if the investigational device can
reanimate a paralyzed limb under voluntary control by the participant's thoughts.

This study plans to enroll participants who have been diagnosed with C4- C6 ASIA A spinal
cord injuries (motor and sensory complete neurologic injuries), who are more than 1 year post
injury, and who are neurologically stable.

Inclusion Criteria:

- Must be 21 years or older.

- Must be tetraplegic (C4- C6 ASIA A).

- 12 months post injury and neurologically stable.

- Participant is willing to comply with all follow-up evaluations at the specified
times.

- Participant is able to provide informed consent prior to enrollment in the study.

- The participant is fluent in English.

- Participant must have a caregiver willing to participate in the study who will provide
care for the surgical site.

Exclusion Criteria:

- No active wound healing or skin breakdown issues.

- No history of poorly controlled autonomic dysreflexia.

- Medical contraindications for general anesthesia, craniotomy, or surgery.

- Diagnosis of acute myocardial infarction or cardiac arrest within previous 6 months.

- Participants with any type of destruction and/or damage to the motor cortex region as
determined by MRI.

- History of psychiatric disturbance or dementia

- Other implantable devices such as heart/brain pacemakers

- Participants who rely on ventilators

- Co-morbid conditions that would interfere with study activities or response to
treatment.

- History of a neurological ablation procedure.

- Labeled contraindication for MRI.

- History of hemorrhagic stroke.

- History of HIV infection or ongoing chronic infection (such as tuberculosis).

- Pregnant or of child-bearing potential and are not taking acceptable methods of
contraception.

- Participation in another FDA device or medication trial that would interfere with the
current study.
We found this trial at
1
site
Columbus, Ohio 43210
Principal Investigator: Marcia Bockbrader, MD, PhD
Phone: 614-685-3141
?
mi
from
Columbus, OH
Click here to add this to my saved trials